(Información remitida por la empresa firmante)
Zinzino group revenue increased with a total of 24%, compared with the previous year.
GOTHENBURG, Sweden, March 3, 2023 /PRNewswire/ -- The revenue in February for Zinzino's sales markets increased by 23 % and amounted to SEK 109.6 (89.0) million. Faun Pharma's external sales increased by 34 % and amounted to SEK 8.7 (6.5) million. Overall, the Group increased revenues by 24 % to SEK 118.3 (95.5) million compared with the previous year.
Accumulated revenue for January - February 2023 increased by 21% to SEK 247.7 (204.5) million.
Revenues were distributed as follows:
Countries in regions:
- The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
- Central Europe: Austria, Germany, Switzerland
- East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
- South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland
- The Baltics: Estonia, Latvia, Lithuania
- North America: Canada, USA
- Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
- Africa: South Africa
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com
Pictures for publication free of charge:
marketing@zinzino.com
Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: certifiedadviser@penser.se
The following files are available for download:
View original content:https://www.prnewswire.co.uk/news-releases/zinzino-ab-publ-preliminary-sales-report-february-2023-301761955.html